Children Nutrition Research Center (Houston, Tx) Site Logo
ARS Home About Us Helptop nav spacerContact Us En Espanoltop nav spacer
Printable VersionPrintable Version     E-mail this pageE-mail this page
Agricultural Research Service United States Department of Agriculture
Search
  Advanced Search
 
Programs and Projects
Subjects of Investigation
Children's Nutrition Research Center Research
Metabolic Research Unit
Body Composition Lab
Eating Behavior Laboratory
Energy Metabolism Lab
Plant Physiology Lab
Analytical Core Labs
 

Research Project: CHILDHOOD EATING BEHAVIORS: PREVENTION OF CHILDHOOD OBESITY AND CHRONIC DISEASES

Location: Children Nutrition Research Center (Houston, Tx)

Title: Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation

Authors
item Cinciripini, Paul - UT MDACC
item Tsoh, Janice - UC SAN FRANCISCO
item Wetter, David - UT MDACC
item Lam, Cho - UT MDACC
item DE Moor, Carl - UT MDACC
item Cinciripini, Lynn - UT MDACC
item Baile, Walter - UT MDACC
item Anderson, Cheryl
item Minna, John - UT SW MED CTR

Submitted to: American Psychological Association (APA) Experimental and Clinical Pharmacology
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: September 20, 2005
Publication Date: November 20, 2005
Citation: Cinciripini, P.M., Tsoh, J.Y., Wetter, D.W., Lam, C., De Moor, C., Cinciripini, L., Baile, W., Anderson, C.B., Minna, J.D. 2005. Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation. American Psychological Association (APA) Experimental and Clinical Pharmacology. 13(4):282-292.

Interpretive Summary: This study looked at the long-term effect of a smoking cessation program that included the nicotine patch, an antidepressant, and behavioral counseling. The addition of the antidepressant did not produce an increase in smoking cessation, as was hypothesized. However, cessation benefits were greater for lighter smokers at baseline (<20 cigarettes per day) than for heavy smokers (> 25 per day).

Technical Abstract: In this study, 147 smokers were randomly assigned to receive either venlafaxine or placebo in conjunction with behavioral counseling (9 weekly sessions) and transdermal nicotine replacement therapy (22 mg/day). Patients began medication 2 weeks before quitting and continued for 18 weeks after quitting, with the daily dose titrated from 150 to 225 mg. in response to symptoms of negative affect and relapse. The results showed no main effect of treatment on abstinence. Post hoc analysis revealed that both at the end of treatment and at the 1-year follow-up smokers consuming less than a pack of cigarettes a day benefited from the addition of venlafaxine to the treatment regimen. Venlafaxine also reduced negative affect for all smokers for up to 6 weeks postcessation. The findings suggest that venlafaxine could have some role to play in the treatment of lighter smokers, in addition to the expected benefits of nicotine replacement therapy and behavioral counseling.

   

 
Project Team
Upchurch, Dan
Thompson, Deborah - Debbe
 
Publications
   Publications
 
Related National Programs
  Human Nutrition (107)
 
 
Last Modified: 05/21/2013
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House